Fibroblasts on a 12 micron channeled surface. 3 |
Fibroblasts on a smooth surface 3 |
In vivo Validation
A series of animal studies (rabbit and canine) were conducted in both an implantable chamber model (intended to assess biologic response) and a dental model to assess the differences in tissue response to an engineered microgeometry versus a machined surface (control). Through these studies, it was shown that a microchannel pattern of 8 and 12 microns improved soft tissue integration,4 controlled cell ingrowth,5 increased bone and tissue attachment6 and reduced bone loss.7
Light photomicrograph showing connective tissue attachment to the laser-machined surface6 |
SEM showing bone integration of the implant body |
Clinical Evidence
To evaluate how dental implants treated with the Laser-Lok microchannels benefit patients, a series of human histologic case studies and prospective controlled studies have been conducted. In a prospective, controlled multi-center study conducted by the Group for Implant Research in Italy, it was shown that, at 37 months post-op, the mean crestal bone loss for implants with Laser-Lok microchannels was only 0.59mm versus 1.94mm for the control implant. The Laser-Lok treated implants form a stable soft tissue seal above the crestal bone.8 Similarly, a prospective, randomized study has been initiated comparing an implant with Laser-Lok microchannels to the 3i Osseotite® NT implant and the Nobel-Biocare Select. This study is evaluating the peri-implant bone and soft tissue complex in patients at 6, 12, 24 and 36 months post-restoration.
Histologic slides showing bone remodeling near the implant surface and no resorption areas at the tips of the threads9 |